Hand Grasping Techniques on Eliciting the Grasp Reflex in Patients With Dementia (GRASP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02925273 |
Recruitment Status :
Completed
First Posted : October 5, 2016
Last Update Posted : October 28, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dementia | Other: palmar grasp without dorsal stimulation Other: standard palmar grasp test with dorsal stimulation | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 1 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | The Effect of Hand Grasping Techniques on Eliciting the Grasp Reflex in Patients With Dementia or Suspected Frontal Lobe Dysfunction |
Study Start Date : | July 2016 |
Actual Primary Completion Date : | May 23, 2018 |
Actual Study Completion Date : | May 23, 2018 |
Arm | Intervention/treatment |
---|---|
Standard
Prospective, grasp techniques will be compared in each patient from the experimental group using a palmar grasp without dorsal stimulation and a standard palmar grasp test with dorsal stimulation on the same patient as the control group
|
Other: palmar grasp without dorsal stimulation
The patient will then be asked to keep the arms at 90 degrees and the researcher will slightly stroke palm and fingers of both hands of the patient simultaneously. After completion of each technique, the presence or absence of the response will be noted. In addition, the prominence of the response on the rating scale will be obtained as explained below. The scaling of the grasp response is as followed:
Other: standard palmar grasp test with dorsal stimulation The patient will be asked to put their arms at 90 degrees and the researcher will hold one hand at the wrist and dorsum of the palm and lightly stroke the palm and fingers. The patient will be instructed to relax hands and not hold on while doing the grasp and see if the response persists. The same technique will be repeated for the patient's other hand. |
- Grasp response [ Time Frame: six months ]The primary objective of the study will be to determine if a change in the performance of the grasp response will lead to a change in the way the response is elicited. The prominence of the grasp response will be scored on a rating scale
- Frontal Lobe release- Glabellar Response [ Time Frame: six months ]The secondary objective during this study will be to determine if other frontal release signs are present in study participants. The glabellar response will be tested.
- Frontal lobe release- Palmomental Response [ Time Frame: six months ]The secondary objective during this study will be to determine if other frontal release signs are present in study participants. The palmomental response will be tested.
- Frontal lobe release- Snout Response [ Time Frame: six months ]The secondary objective during this study will be to determine if other frontal release signs are present in study participants. The snout response will be tested.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Ability to sign informed consent or have a surrogate present to sign the consent
- Age 18 or above
- Patients are diagnosed with dementia, Alzheimer's disease, or frontal lobe dysfunction
- Medications are to remain stable during the course of the study except for emergency modifications.
Exclusion Criteria:
- Inability to obtain informed consent from patient or surrogate
- Unable to follow commands.
- Physical restrictions (i.e. spasticity of hands/arms, upper extremity amputation)
- Other comorbidities such as muscular diseases, hepatic encephalopathy, renal failure, down syndrome, NPH, depression, and cerebral palsy.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02925273
United States, New Jersey | |
Rowan University School of Osteopathic Medicine | |
Stratford, New Jersey, United States, 08084 |
Principal Investigator: | Donald Barone, DO | Rowan University School of Osteopathic Medicine |
Responsible Party: | Lauren Fedor, Program Manager, Rowan University |
ClinicalTrials.gov Identifier: | NCT02925273 |
Other Study ID Numbers: |
GRASP |
First Posted: | October 5, 2016 Key Record Dates |
Last Update Posted: | October 28, 2019 |
Last Verified: | October 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
dementia |
Dementia Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Neurocognitive Disorders Mental Disorders |